Astellas Pharma-posted 2 months ago
Remote • Northbrook, IL
5,001-10,000 employees
Chemical Manufacturing

The Global Statistical Lead (GSTATL) for Solid Tumor Oncology is a compound level leader within the Quantitative Science & Evidence Generation (QSEG) organization, accountable for driving the statistical and analytical strategy for a compound or indication across its full development lifecycle. This position leads a cross-functional, integrated quantitative team supporting evidence generation and decision-making, with responsibility spanning clinical trial statistics, exploratory statistics, medical affairs statistics, real-world evidence (RWE), safety/pharmacovigilance (PV) statistics, statistical programming, biomarker statistics, and advanced analytics. The role ensures consistency and scientific excellence across studies, indications, and evidence types-while enabling innovation in statistical methodology, clinical development optimization, and external engagement. The GSTATL plays a key role in regulatory and payer strategy, as well as internal governance and portfolio planning for solid tumor assets.

  • Serve as the compound-level statistical lead for solid tumor oncology, responsible for end-to-end quantitative strategy supporting clinical development, evidence generation, and regulatory/payer interactions.
  • Lead development of integrated statistical strategies across all relevant study types and functions (e.g., phase 1b/2 signal-seeking, pivotal, exploratory, RWE, post-marketing).
  • Align statistical and analytical approaches with the target product profile (TPP), development strategy, and external evidence needs.
  • Lead and coordinate statistical and analytics contributions from a broad QSEG team, including clinical trial biostatisticians, exploratory oncology statisticians, medical affairs statisticians, statistical programmers, biomarker/statistical genetics experts in oncology, RWE analysts/statistical epidemiologists, safety/PV statisticians, and advanced analytics and modeling specialists.
  • Ensure scientific alignment, quality, and integration across all statistical contributions at the compound level.
  • Represent Astellas on all statistical matters in global regulatory interactions (e.g., FDA, EMA, PMDA).
  • Guide preparation of statistical content for regulatory submissions, briefing packages, and health technology assessment (HTA) dossiers.
  • Lead the development of statistical components of payer evidence strategies, including indirect comparisons and external control methodologies.
  • Champion the use of oncology-appropriate innovations, including Bayesian designs, adaptive trial designs, external controls, tumor-agnostic approaches, and AI/ML tools to enhance study design and signal detection.
  • Promote exploratory data analysis, modeling, and simulation to support rapid development decisions in Solid Tumor trials.
  • Integrate clinical, biomarker, safety, and real-world evidence to drive cohesive, data-driven development and access strategies.
  • Mentor statisticians and analytics professionals across QSEG, supporting both scientific development and career growth.
  • Share knowledge and best practices across study teams and therapeutic areas.
  • Contribute to internal training, methodology development, and talent pipeline initiatives.
  • Participate in global asset governance and development team meetings, influencing decisions with rigorous statistical insight.
  • Collaborate with Clinical Development, Medical Affairs, Regulatory, Market Access, and Commercial to ensure alignment on evidence planning.
  • Lead or contribute to internal initiatives, including standardization efforts, methodology forums, and innovation networks.
© 2024 Teal Labs, Inc
Privacy PolicyTerms of Service